[Treatment of the asthmatic state. Current status (apropos of 18 cases)].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000628:therapy*; D001815:Bloodletting; D002245:Carbon Dioxide / Q000097:blood; D003907:Dexamethasone / Q000627:therapeutic use; D004417:Dyspnea / Q000628:therapy; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy; D011379:Prognosis; D012121:Respiration, Artificial
D000318:Adrenergic beta-Agonists; D000900:Anti-Bacterial Agents; D002245:Carbon Dioxide; D000628:Aminophylline; D003907:Dexamethasone; D010100:Oxygen; D006854:Hydrocortisone
Traitement de l'état de mal asthmatique. Conception actuelle (à propos de 18 cas.